Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saridegib in Advanced Chondrosarcoma
NCT01310816Phase 2Completed
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Start
- Feb 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of patidegib in chondrosarcoma, sponsored by Infinity Pharmaceuticals, Inc.. Started Feb 2011; status: completed.
02
Drugs
patidegib
03
Conditions
chondrosarcoma
Beyond the preview
Go deeper on NCT01310816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01310816.